AnterogenCoLtd (Korea) Top Management
065660 Stock | KRW 15,570 190.00 1.24% |
Analysis of AnterogenCoLtd's management performance can provide insight into the company performance.
AnterogenCoLtd |
Symbol | 065660 |
Name | AnterogenCoLtd |
Type | Stock |
Country | Republic of Korea |
Exchange | KQ |
Information on AnterogenCoLtd Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
AnterogenCoLtd Management Team Effectiveness
The company has return on total asset (ROA) of (0.0231) % which means that it has lost $0.0231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.9178) %, meaning that it generated substantial loss on money invested by shareholders. AnterogenCoLtd's management efficiency ratios could be used to measure how well AnterogenCoLtd manages its routine affairs as well as how well it operates its assets and liabilities.AnterogenCoLtd Workforce Comparison
AnterogenCoLtd is rated below average in number of employees category among its peers. The total workforce of Pharmaceuticals industry is presently estimated at about 473. AnterogenCoLtd claims roughly 6.0 in number of employees contributing just under 2% to equities listed under Pharmaceuticals industry.
The company has Profit Margin (PM) of (1.32) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.77. AnterogenCoLtd Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AnterogenCoLtd Price Series Summation is a cross summation of AnterogenCoLtd price series and its benchmark/peer.
About AnterogenCoLtd Management Performance
The success or failure of an entity such as AnterogenCoLtd often depends on how effective the management is. AnterogenCoLtd management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AnterogenCoLtd management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AnterogenCoLtd management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of AnterogenCoLtd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AnterogenCoLtd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AnterogenCoLtd's management manipulating its earnings.
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |